Astrana Health, Inc. Reports Third Quarter 2025 Results

Core Insights - Astrana Health, Inc. reported strong third-quarter results for 2025, with significant revenue growth and successful integration of Prospect Health [2][9][10] - The company is focused on enhancing its care delivery platform and maintaining strong clinical and cost performance despite some delays in full-risk contract transitions [2][9] Financial Highlights for Q3 2025 - Total revenue reached $956.0 million, a 100% increase from $478.7 million in Q3 2024 [9][10] - Adjusted EBITDA was $68.5 million, up 52% from $45.2 million in the same quarter last year [10][22] - Net income attributable to Astrana was $0.4 million, with diluted earnings per share of $0.01 [10][20] Financial Highlights for Nine Months Ended September 30, 2025 - Total revenue for the nine months was $2,231.2 million, a 63% increase from $1,369.3 million [10][19] - Adjusted EBITDA for the nine months was $153.0 million, up 13% from $135.3 million [10][22] - Net income attributable to Astrana for the nine months was $16.5 million, with diluted earnings per share of $0.33 [10][20] Recent Operating Highlights - Care Partners revenue was $897.7 million, a 97% increase from $455.8 million in Q3 2024 [10][19] - The company successfully closed the acquisition of Prospect Health, which exceeded performance expectations [9][10] - Astrana announced a strategic partnership with Intermountain Health to enhance care access and improve patient outcomes in southern Nevada [10][19] Guidance for 2025 - Updated guidance for total revenue is projected between $3.1 billion and $3.18 billion, with Adjusted EBITDA expected between $200 million and $210 million [11][29] - The guidance reflects adjustments for full-risk contract delays unrelated to core performance [9][11] Cash Flow and Balance Sheet Highlights - Cash and cash equivalents as of September 30, 2025, were $462.2 million, up from $288.5 million at the end of 2024 [17][21] - Total assets increased to $2,237.2 million from $1,354.9 million at the end of 2024 [17][18] - Total liabilities rose to $1,682.5 million from $840.7 million at the end of 2024 [17][18]